Home068270 • KRX
add
Celltrion Inc
Nakaraang pagsara
₩173,700.00
Sakop ng araw
₩173,000.00 - ₩176,500.00
Sakop ng taon
₩157,500.00 - ₩241,000.00
Market cap
37.66T KRW
Average na Volume
548.33K
P/E ratio
191.13
Dividend yield
0.29%
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (KRW) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 881.93B | 31.18% |
Gastos sa pagpapatakbo | 255.73B | 148.90% |
Net na kita | 85.59B | -61.41% |
Net profit margin | 9.71 | -70.58% |
Kita sa bawat share | 414.00 | -73.48% |
EBITDA | 283.35B | -13.69% |
Aktuwal na % ng binabayarang buwis | 52.82% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (KRW) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.18T | 190.82% |
Kabuuang asset | 20.31T | 209.79% |
Kabuuang sagutin | 3.28T | 57.87% |
Kabuuang equity | 17.03T | — |
Natitirang share | 206.09M | — |
Presyo para makapag-book | 2.12 | — |
Return on assets | 2.57% | — |
Return on capital | 2.70% | — |
Cash Flow
Net change in cash
| (KRW) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 85.59B | -61.41% |
Cash mula sa mga operasyon | 265.31B | 653.96% |
Cash mula sa pag-invest | -136.41B | -38.41% |
Cash mula sa financing | -47.95B | 61.66% |
Net change in cash | 68.24B | 125.70% |
Malayang cash flow | 265.58B | 234.44% |
Tungkol
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Itinatag
2002
Website
Mga Empleyado
1,074
